Latest Portfolio Companies News

Scalare Partners has bolstered its founder support ecosystem through the acquisitions of Tank Stream Labs and Planet Startup, already driving significant revenue growth and expanding its national footprint.

Whitefield Industrials reports a $10.5 million net profit for H1 2026, with a strong 17.1% annualised return over three years, maintaining its track record of benchmark outperformance and announcing a 10.5 cent fully franked dividend.

Bailador Technology Investments reported a robust FY25 with a 33% gross IRR from its private portfolio, $41 million deployed in new and follow-on investments, and a strong final dividend of 3.6 cents per share.

Pacific Current Group has announced an on-market buy-back of up to 2 million shares, representing nearly 7% of its capital, aiming to enhance earnings per share and capital efficiency.

The Supreme Court of New South Wales has approved the scheme for Pacific Equity Partners to acquire Johns Lyng Group, setting the stage for a significant ownership change and trading suspension on the ASX.

Scalare Partners has acquired Brisbane-based virtual CFO provider Planet Startup, enhancing its services for early-stage tech ventures and signaling continued growth through strategic acquisitions.

Forrestania Resources has completed its acquisition of the British Hill Gold Project near Southern Cross, Western Australia, and appointed MBS Environmental to lead mine development planning.

Next Science has finalised the sale of nearly all its assets to OSARTIS GmbH for US$50 million, with plans to return approximately US$30 million net proceeds to shareholders following legal and tax review.

Scalare Partners has successfully closed a $3.09 million capital raise, combining a $3 million placement and a Share Purchase Plan, to fund its acquisition of Tank Stream Labs and expand its technology portfolio.

Next Science Limited reported a 7% revenue decline and a 20% reduction in net loss for H1 2025, alongside a major $50 million asset sale agreement with OSARTIS GmbH. The transaction, approved by shareholders, signals a strategic pivot for the biofilm-focused medical device company.

Scalare Partners Holdings Limited reported a 26% increase in total revenues to $3.54 million for FY25, driven by strong growth in founder support services and strategic acquisitions. However, the Group recorded a statutory loss of $2.65 million amid increased structural and compliance costs following its ASX listing and expansion.

Touch Ventures Limited reported a significantly reduced net loss of $4.8 million for H1 2025, reflecting improved portfolio performance and a fresh five-year management agreement. Key strategic moves include a write-down of Sendle and a post-period valuation uplift in Ordermentum.